Cargando…
MON-447 Impact Of Cortisone And Glucocorticoid Metabolites On Bone Turnover Markers in Male Patients With Hypopituitarism
Background: Glucocorticoid therapy is the most common cause of iatrogenic osteoporosis. Less is known on the effect of glucocorticoids on bone remodeling when used as replacement therapy in patients with adrenal insufficiency. Enhanced intracellular conversion of cortisone to active cortisol, by 11b...
Autores principales: | Dineen, Rosemary, Behan, Lucy-Ann, kelleher, grainne, Hannon, Mark, Brady, Jennifer, Rogers, Bairbre, Keevil, Brian, Tormey, William, Smith, Diarmuid, Thompson, Chris, McKenna, Malachi J, Arlt, Wiebke, Stewart, Paul, Agha, Amar, Sherlock, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550632/ http://dx.doi.org/10.1210/js.2019-MON-447 |
Ejemplares similares
-
The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy
por: Dineen, Rosemary, et al.
Publicado: (2020) -
MON-261 Pituitary Abscess Presenting as Pituitary Macroadenoma Causing Hypopituitarism and Acute Meningitis; A Wolf in Sheep’s Clothing
por: Jalil, Fatima, et al.
Publicado: (2020) -
MON-304 Prolactin as a Surrogate Marker to Predict Long Term Postoperative Hypopituitarism After Transsphenoidal Resection of Pituitary Adenomas
por: German, Massiell, et al.
Publicado: (2020) -
SUN-447 Screening of Genetic Alterations in Patients with Giant Prolactinomas
por: Chaves, Carolina, et al.
Publicado: (2019) -
MON-LB49 Atypical Presentation for a 5.5-cm Macroprolactinoma: Unilateral Visual Loss and Only Partial Hypopituitarism; Asymptomatic Hypogonadism
por: panjawatanan, panadeekarn, et al.
Publicado: (2020)